Innoviva, Inc.
(NASDAQ : INVA)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
MNKMallinckrodt Plc
2.64%35.6121.1%$129.42m
PRGOPerrigo Co. Plc
1.55%74.096.7%$116.86m
SHPGShire PLC Sponsored ADR
0.48%171.240.4%$114.84m
ENDPEndo International Plc
2.69%16.068.9%$91.42m
JAZZJazz Pharmaceuticals Plc
0.43%174.552.2%$72.54m
ICPTIntercept Pharmaceuticals, Inc.
0.40%103.8318.7%$68.90m
SAGESAGE Therapeutics, Inc.
-1.90%149.209.6%$56.08m
UTHRUnited Therapeutics Corporation
-0.33%125.2014.4%$50.39m
CTLTCatalent Inc
0.39%41.092.6%$48.00m
GWPHGW Pharmaceuticals PLC Sponsored ADR
-2.09%133.226.8%$42.32m
SUPNSupernus Pharmaceuticals, Inc.
-0.09%44.766.2%$40.18m
PTLAPortola Pharmaceuticals, Inc.
-1.60%25.187.7%$39.89m
ICLRICON Plc
-0.97%142.294.2%$39.60m
ZGNXZogenix, Inc.
-4.53%46.4011.9%$35.75m
HZNPHorizon Pharma plc
0.24%20.627.5%$32.82m

Company Profile

Innoviva, Inc. engages in the development, commercialization, and financial management of bio-pharmaceuticals. Its portfolio includes Relvar Breo Ellipta, which is a once-daily combination medicine consisting of a long-acting beta2 agonist, vilanterol, and an inhaled corticosteroid, fluticasone furoate; and Anoro Ellipta, a once-daily medicine combining a long-acting muscarinic antagonist, umeclidinium bromide, LABA, VI. The company was founded by P. Roy Vagelos, Mathai Mammen, and George M. Whitesides in November 1996 and is headquartered in Brisbane, CA.